AI Article Synopsis
- Diabetes and NAFLD have a two-way relationship, increasing the risk of liver complications, prompting a study on the impact of fasting glucose variability in early adulthood on NAFLD later in life.* -
- The study tracked 2467 young adults over 25 years, analyzing their fasting glucose variability and later diagnosing NAFLD using specific criteria on CT scans.* -
- Results indicated that individuals with higher fasting glucose variability in early adulthood had nearly three times the odds of developing NAFLD by middle age, suggesting that monitoring glucose fluctuations could identify those at higher risk.*
Article Abstract
Context: Diabetes has a bidirectional association with nonalcoholic fatty liver disease (NAFLD) and increases the risk of cirrhosis and related complications.
Objective: To investigate the association between visit-to-visit fasting glucose (FG) variability in early adulthood and NAFLD in middle age.
Methods: This prospective cohort study included 2467 Black and White adults aged 18 to 30 years at baseline (1985-1986) who were followed over 25 years in the Coronary Artery Risk Development in Young Adults Study. FG variability measures included coefficient of variation about the mean FG (CV-FG), the SD of FG (SD-FG), and the average real variability of FG (ARV-FG) across 25 years (year 0, 7, 10, 15, 20, and 25 examinations). NAFLD was defined as liver attenuation ≤ 40 Hounsfield units on computed tomography scan at year 25 examination after excluding other causes of hepatic steatosis.
Results: Of the 2467 participants, 241 (9.8%) had NAFLD at year 25. In multivariate analysis, the odds ratio for NAFLD was 2.80 (95% CI, 1.69-4.64; P trend < 0.001) for the fourth quartile vs first quartile of CV-FG after adjusting for confounding variables, including mean FG. Similar results were observed for SD-FG and ARV-FG.
Conclusion: Greater visit-to-visit FG variability in early adulthood was associated with higher risk of NAFLD in middle age independent of mean FG level. FG variability may help identify individuals at high risk for NAFLD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272423 | PMC |
| http://dx.doi.org/10.1210/clinem/dgac122 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk prediction of diabetic retinopathy based on visit-to-visit fasting blood glucose indices.
Front Endocrinol (Lausanne)
October 2024
National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Objective: The long-term glucose monitoring is essential to the risk assessment of diabetic retinopathy (DR), the aim of this study was to investigate the predictive ability of visit-to-visit fasting blood glucose (FBG) indices on the risk of DR.
Methods: This was a community-based, cohort study conducted from 2013 to 2021. DR was diagnosed by digital fundus photography.
Glycemic variability's impact on painful diabetic peripheral neuropathy in type 2 diabetes patients.
Sci Rep
September 2024
Department of Neurology, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan.
Hyperglycemia in type 2 diabetes leads to diabetic peripheral neuropathy (DPN) and neuropathic pain, yet the association between glycemic variability and painful DPN remains insufficiently evidenced. To address this, we conducted a prospective longitudinal cohort study involving adult type 2 diabetes patients at a medical center. DPN was identified using the Michigan Neuropathy Screening Instrument (MNSI), and neuropathic pain was assessed with the Taiwan version of the Douleur Neuropathique 4 (DN4-T) questionnaire.
View Article and Find Full Text PDFThe association between index-year, average, and variability of the triglyceride-glucose index with health outcomes: more than a decade of follow-up in Tehran lipid and glucose study.
Cardiovasc Diabetol
August 2024
Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, P.O. Box 19395-4763, Tehran, Islamic Republic of Iran.
Background: The association between baseline triglyceride glucose index (TyG index) and incident non-communicable diseases, mainly in Asian populations, has been reported. In the current study, we aimed to evaluate the association between index-year, average, and visit-to-visit variability (VVV) of the TyG index with incident type 2 diabetes mellitus (T2DM), hypertension, cardiovascular disease (CVD), and all-cause mortality among the Iranian population.
Methods: The study population included 5220 participants (2195 men) aged ≥ 30 years.
Visit-to-visit variability in multiple biological measurements and cognitive performance and risk of cardiovascular disease: A cohort study.
Cereb Circ Cogn Behav
May 2024
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Article Synopsis
- The study aimed to investigate how changes in multiple biological measurements (like blood pressure and cholesterol) over time affect cognitive performance and cardiovascular disease risk.
- Data from the ORIGIN trial were analyzed, focusing on how the variability in these measurements relates to cognitive tests (MMSE score) and cardiovascular events.
- Results showed that higher variability in certain biological measures is linked to worse cognitive performance and a greater risk of cardiovascular issues, with a stronger impact observed in individuals with high variability in four or more measurements.
Fasting glucose variability and risk of dementia in Parkinson's disease: a 9-year longitudinal follow-up study of a nationwide cohort.
Front Aging Neurosci
January 2024
Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Background: Diabetes is associated with an increased risk of Parkinson's disease dementia (PDD); however, it is unknown whether this association is dependent on continuous hyperglycemia, hypoglycemic events, or glycemic variability. We aimed to investigate the relationship between visit-to-visit fasting glucose variability and PDD development in patients with Parkinson's disease (PD).
Methods: Using data from the Korean National Health Insurance Service, we examined 9,264 patients aged ≥40 years with Parkinson's disease (PD) who underwent ≥3 health examinations and were followed up until December 2019.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!